📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial (2015)

First Author: Sutherland K

Attributed to: Centre for Health service and Academic Partnership in Translational eHealth Research (CHAPTER) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0137834

PubMed Identifier: 26382239

Publication URI: http://europepmc.org/abstract/MED/26382239

Type: Journal Article/Review

Parent Publication: PLOS ONE

Issue: 9

ISSN: 1932-6203